Interestingly, in an in vitro cell model of steatosis, similar to the one we used in this study, Seo and colleagues [41] recently showed that Ex-4 treatment significantly reduced the expression of both PPARγ and SREBP-1c. This evidence concerns the gene SREBF1 and steatosis.